Tilray Brands, Inc. TLRY shares are trading higher Monday amid continued momentum in the cannabis sector on U.S. efforts to reschedule marijuana.
The Details:
Cannabis stocks have been on a hot streak since Aug. 31 when it was reported that the Department of Health and Human Services sent a letter to the DEA recommending the reclassification of marijuana from a Schedule I to Schedule III substance.
The stock is moving higher on heavy trading volume with more than 43 million shares having been traded, compared to the stock's 100-day average of 27.631 million shares.
According to data from Benzinga Pro, 13.22% of available shares are being sold short, and shares of TLRY are up more than 45% over the last 30 days.
Related News: What's Going On With Aurora Cannabis Stock
TLRY Price Action: According to Benzinga Pro, Tilray Brands shares are up 7.45% at $3.24 at the time of publication.
Image: herbalhemp from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.